FDA approves first non-opioid pain medicine in more than 20 years
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
Too Much Vitamin B6 Can Be Toxic. Here's What You Need to Know.
In recent weeks, reports have been circulating about severe reactions in people who've taken over-the-counter vitamin B6 ...
GBS outbreak: Nadda asks state to work with central agencies, identify trigger points
GBS is a rare disorder where the immune system attacks the peripheral nervous system which carries signals from the brain and spinal cord to the rest of the body, causing muscle weakness and paralysis ...
New Bedford pastor nearly paralyzed from a rare disease. He's made a miraculous comeback.
Christian Fellowship Center Lead Pastor Brian Dube is making a miraculous recovery from a case of near-fatal paralysis from a ...
The American Journal of Managed Care2d
FDA Approves First Subcutaneous Apomorphine Device for Parkinson Disease
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
Malaysian Reserve1d
Saluda Medical Announces Presentation of New Clinical Data at the 2025 NANS Annual Meeting
Presentations Included First Human Data on EVA™, Saluda's Automated SCS Programming Platform MINNEAPOLIS, Feb. 5, 2025 ...
Scientific American6d
What Is Journavx, the New Opioid-Free Painkiller from Vertex?
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease
ONAPGOis the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s ...
Prosthetic limb gains more natural control through hand–brain connection
Researchers are paving the way for the design of bionic limbs that feel natural to users. They demonstrate the connection ...
Seven women say they endured domestic violence, then prison. These are their stories
Seven women filed for re-sentencing under the Oklahoma Survivors Act, a new law that considers domestic violence evidence.
FDA approves new type of nonopioid painkiller for acute pain
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
The Street Journal4d
What is the Guillain-Barré Syndrome?
India's western city of Pune is battling rising cases of the Guillain-Barré Syndrome (GBS), with at least 111 identified cases just in the last three weeks, local media outlets reported on Tuesday ...